Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2018 pubmed 30 citations

A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of Cathelicidin LL-37 Controls the Immunostimulatory Potential of Cell-Free DNA.

Wong. Alicia A; Bryzek. Danuta D; Dobosz. Ewelina E; Scavenius. Carsten C; Svoboda. Pavel P; Rapala-Kozik. Maria M; Lesner. Adam A; Frydrych. Ivo I; Enghild. Jan J; Mydel. Piotr P; Pohl. Jan J; Thompson. Paul R PR; Potempa. Jan J; Koziel. Joanna J

Key Findings

  • Citrullination of LL-37 by PAD enzymes blocks its ability to bind DNA and activate plasmacytoid dendritic cells
  • The loss of activity increases with the number of citrullinated arginine residues
  • Replacing arginine with homoarginine prevents PAD‑mediated loss of function, while carbamylation has no effect

Practical Outcomes

  • For DIY health enthusiasts, the work hints that modulating PAD activity (e.g., with PAD inhibitors) could preserve LL-37’s immune‑boosting role, but there’s no ready‑to‑use supplement or dosage recommendation yet. More research is needed before applying this to longevity or auto‑immune strategies.

Summary

LL-37 is a natural peptide that helps immune cells sense stray DNA, but when it gets chemically altered by PAD enzymes (a process called citrullination), it can no longer bind DNA or trigger those immune cells, which may lower the risk of auto‑immune flare‑ups. The study shows the more parts of LL-37 that are citrullinated, the weaker its effect, and that swapping certain building blocks can protect its activity.

Abstract

LL-37, the only human cathelicidin that is released during inflammation, is a potent regulator of immune responses by facilitating delivery of oligonucleotides to intracellular TLR-9, thereby enhancing the response of human plasmacytoid dendritic cells (pDCs) to extracellular DNA. Although important for pathogen recognition, this mechanism may facilitate development of autoimmune diseases. In this article, we show that citrullination of LL-37 by peptidyl-arginine deiminases (PADs) hindered peptide-dependent DNA uptake and sensing by pDCs. In contrast, carbamylation of the peptide (homocitrullination of Lys residues) had no effect. The efficiency of LL-37 binding to oligonucleotides and activation of pDCs was found to be inversely proportional to the number of citrullinated residues in the peptide. Similarly, preincubation of carbamylated LL-37 with PAD2 abrogated the peptide's ability to bind DNA. Conversely, LL-37 with Arg residues substituted by homoarginine, which cannot be deiminated, elicited full activity of native LL-37 regardless of PAD2 treatment. Taken together, the data showed that citrullination abolished LL-37 ability to bind DNA and altered the immunomodulatory function of the peptide. Both activities were dependent on the proper distribution of guanidinium side chains in the native peptide sequence. Moreover, our data suggest that cathelicidin/LL-37 is citrullinated by PADs during NET formation, thus affecting the inflammatory potential of NETs. Together this may represent a novel mechanism for preventing the breakdown of immunotolerance, which is dependent on the response of APCs to self-molecules (including cell-free DNA); overactivation may facilitate development of autoimmunity.

Study Information

Provider

pubmed

Year

2018

Date

2018-02-23T00:00:00.000Z

DOI

10.4049/jimmunol.1701391

Citations

30

References

41